Connor Clark & Lunn Investment Management Ltd. Boosts Stock Position in Definitive Healthcare Corp. (NASDAQ:DH)

Connor Clark & Lunn Investment Management Ltd. grew its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 28.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 146,623 shares of the company’s stock after acquiring an additional 32,071 shares during the period. Connor Clark & Lunn Investment Management Ltd. owned 0.13% of Definitive Healthcare worth $603,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in DH. PNC Financial Services Group Inc. increased its stake in Definitive Healthcare by 928.3% in the fourth quarter. PNC Financial Services Group Inc. now owns 156,997 shares of the company’s stock valued at $645,000 after acquiring an additional 141,729 shares during the last quarter. M&T Bank Corp grew its stake in shares of Definitive Healthcare by 99.2% during the fourth quarter. M&T Bank Corp now owns 97,877 shares of the company’s stock valued at $402,000 after buying an additional 48,746 shares during the last quarter. Bank of New York Mellon Corp grew its stake in shares of Definitive Healthcare by 35.9% in the fourth quarter. Bank of New York Mellon Corp now owns 229,143 shares of the company’s stock worth $942,000 after purchasing an additional 60,559 shares during the last quarter. Ieq Capital LLC bought a new stake in shares of Definitive Healthcare in the fourth quarter worth about $51,000. Finally, New York State Common Retirement Fund grew its stake in shares of Definitive Healthcare by 3.2% in the fourth quarter. New York State Common Retirement Fund now owns 771,792 shares of the company’s stock worth $3,172,000 after purchasing an additional 23,815 shares during the last quarter. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Price Performance

NASDAQ DH opened at $2.81 on Friday. Definitive Healthcare Corp. has a 12 month low of $2.55 and a 12 month high of $8.35. The stock has a market cap of $317.28 million, a price-to-earnings ratio of -0.91, a PEG ratio of 4.06 and a beta of 1.51. The company’s 50 day moving average is $4.19 and its two-hundred day moving average is $4.31. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33.

Definitive Healthcare (NASDAQ:DH) last released its quarterly earnings data on Thursday, February 27th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.04). The company had revenue of $62.29 million for the quarter, compared to the consensus estimate of $60.60 million. Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. As a group, research analysts anticipate that Definitive Healthcare Corp. will post 0.16 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. The Goldman Sachs Group lowered their price objective on shares of Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating for the company in a report on Tuesday, March 4th. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research report on Thursday, January 16th. Stephens initiated coverage on shares of Definitive Healthcare in a report on Friday, December 20th. They set an “equal weight” rating and a $5.00 price target on the stock. Finally, Barclays dropped their price target on shares of Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating on the stock in a report on Monday, March 3rd. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $5.35.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.